Skip to main content
Clinical Trials/NCT05168241
NCT05168241
Completed
Not Applicable

The Effect of Singing or Playing Melodica on Disease Symptoms, Self-Efficacy Level and Exercise Capacity in Chronic Obstructive Pulmonary Patients

Karadeniz Technical University1 site in 1 country30 target enrollmentSeptember 1, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Chronic Obstructive Pulmonary Disease
Sponsor
Karadeniz Technical University
Enrollment
30
Locations
1
Primary Endpoint
Modifiye Medical Research Council (mMMC) Dyspnea scale
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

This study was conducted as a randomized controlled experimental study to determine the effect of singing or playing melodica activity applied to chronic obstructive pulmonary patients on symptoms, self-efficacy level, and exercise capacity of patients.

Detailed Description

The research was carried out in the chest diseases polyclinics of a hospital in Trabzon city center between September 2020 and August 2021 with 30 patients: 15 in the control group and 15 in the song/melodica group. Based on Pender's health promotion model, the control group received training and counseling for ten weeks, including face-toface training and telephone follow-up. According to Pender's health promotion model, patients in the song/melodica group were given face-to-face training once, singing/playing the melodica training twice, and counseling and follow-up over the phone twice, with 15- day intervals. The data were collected with a patient information form and scales examining disease symptoms, self-efficacy, and exercise capacity. To evaluate the data, ttest, Mann-Whitney U, ANOVA, Kruskal Wallis test were used for independent groups to evaluate changes over time, and paired two-sample t-test, Wilcoxon test, and ANOVA test were used in repetitive measurements for dependent groups. .

Registry
clinicaltrials.gov
Start Date
September 1, 2020
End Date
August 31, 2021
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

ELİF OKUR

PhD

Karadeniz Technical University

Eligibility Criteria

Inclusion Criteria

  • 18 years and older,
  • Having been diagnosed with COPD by the physician based on the results of the pulmonary function test taken with spirometry according to the GOLD criteria, who are in the stable period of COPD,
  • Applying to thoracic polyclinics,
  • not bedridden,
  • Does not have vision and hearing problems that do not interfere with communication,
  • Patients who can complete the six-minute walk test,
  • Willing to sing and/or play melodica
  • Patients who agreed to participate in the study and who read and signed the informed consent form were included in the sample.

Exclusion Criteria

  • Those who do not agree to participate in the research,
  • with asthma,
  • with a diagnosis of cancer,
  • with a diagnosis of Covid-19,
  • Having unstable angina or myocardial infarction in the last 1 month,
  • Having a resting heart rate \>120/min,
  • Patients with a resting systolic blood pressure of \>180 mmHg and a diastolic blood pressure of \>100 mmHg (183) were excluded from the study.

Outcomes

Primary Outcomes

Modifiye Medical Research Council (mMMC) Dyspnea scale

Time Frame: 10 weeks

Dyspnea scores of the patients were recorded in the pre-test and post-test.The Medical Research Council Scale (mMRC) consists of five items based on various physical activities that cause dyspnea. On this scale, patients are asked to simply select the activity that produces the feeling of dyspnea. Scoring is between 0-4. Minimum, maximum, median and mean values were evaluated for each group and compared between groups.

Secondary Outcomes

  • COPD Assessment Test (CAT)(10 weeks)

Study Sites (1)

Loading locations...

Similar Trials